DFX Intelligence
Private Equity Intelligence
Firms, funds, people, portfolio companies and transactions from sworn filings and cited announcements, kept as a graph with a date and a source on every edge. Reported gross assets are never fund size, regulatory AUM is never dry powder, and a deal value prints only when someone disclosed it.
The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.
Firms / F•••••• C•••••• A••••••• A•
F•••••• C•••••• A••••••• A•
F•••••• Capital is a Stockholm and London based investment company with a truly entrepreneurial, global and long-term perspective.
Classification
- Class
- Buyout firmprobable, confidence 65%
- Basis
- R6: 1 of 1 distinct vehicles are sworn Private Equity Funds
- Size band
- Middle marketdefined by: proxy: $1.18bn Private Equity Fund GAV on the Form ADV filed 2024-03-27
Classification history (1)
- Sep 13, 2026Buyout firm (probable, 65%, cls-pe-1)R6: 1 of 1 distinct vehicles are sworn Private Equity Funds
Regulatory footprint (Form ADV)
- Adviser type
- exempt reporting adviser
- Form ADV filings
- Nov 17, 2022 to Mar 27, 2024
- RAUM
- unknownregulatory assets under management of the adviser; not dry powder, not a fund size
- PE funds, latest filing
- 1
- PE fund GAV, latest filing
- $1.2Breported gross assets (Form ADV), not fund size
- All private fund GAV
- $1.2Bevery private fund type, latest filing
- 2024 PE fund GAV
- unknownsum over funds typed Private Equity Fund with a 2024 or later as-of date
- PE share of funds, lifetime
- 100%
- Fund type mix
- filed 2024-03-27, latest gav Private Equity Fund $1.2B, latest counts Private Equity Fund 1, lifetime distinct Private Equity Fund 1
- Employees
- unknown
- Headquarters
- Stockholm, Sweden
- Office address
- STUREGATAN 10, Stockholm, 114 36
- Business phone
- +46 732 552 181
Stated criteria beside observed behaviour
10 observed deals
Stated by the firm
- Sectors
- not stated or not yet read
- Geography
- Europe
- Revenue
- not stated or not yet read
- EBITDA
- not stated or not yet read
- Enterprise value
- not stated or not yet read
- Equity check
- not stated or not yet read
- Control
- majority,minority
- Thesis
- We want to invest in businesses where we can add tangible value as an enabling partner to entrepreneurs, management teams and fellow co-owners with significant growth ambitions.
Observed from deals on record
- roles
- unknown 10
- period
- to unknown, from unknown, undated holdings 10, dated observations 0
- window
- last unknown, first unknown
- control
- unknown 10
- companies
- 10
- geography
- investments
- 10
- seller kinds
- transactions
- 0
- cadence by year
- platform add on
- add ons 0, platforms 0, add ons per platform unknown
- sector known for
- 1
- disclosed value usd
- n 0
- sector distribution
- count 1, share 0.1, value healthcare services, examples Europe’s leading family of animal hospitals
- holding period years
- n 0
- repeat counterparties
- subsector distribution
- count 1, share 0.1, value veterinary, examples Europe’s leading family of animal hospitals
10 companies on the graph (0 transactions); most in healthcare services (1); no dated observations
Funds
0 on record, 1 more on the reporting tape
Gross assets by year from the annual reporting tape
These funds appear in this adviser’s Form ADV reporting. One row per fund per year (the latest filing of that year). Values are reported gross assets, not fund size.
| Fund | Type (ADV) | Years | Path | Latest reported GAV | Source |
|---|---|---|---|---|---|
| F•••••• C•••••• A• | Private Equity Fund | 2022 to 2024 | $1.2B filed Mar 27, 2024 | adviserinfo.sec.gov |
Team
5 current, 0 former
Managing partner (1)
- T•••••• S•••• J•••• B•••••• · Deputy Ceo · since Sep 1, 2022 SEC Form ADV filing data 2011 to 2024 (Schedule D 7.B.(1) private funds, Schedules A/B, 1.I websites)
Partner (2)
- C••• G•••••• L•••••• F••••••••• · Shareholder · since Sep 1, 2022 SEC Form ADV filing data 2011 to 2024 (Schedule D 7.B.(1) private funds, Schedules A/B, 1.I websites)
- K••••••• M•••••••• · Shareholder · since Sep 1, 2022 SEC Form ADV filing data 2011 to 2024 (Schedule D 7.B.(1) private funds, Schedules A/B, 1.I websites)
Platform (2)
- A•••••••• M•••••••• C•••• B•••••••• · Cfo · since Sep 1, 2022 SEC Form ADV filing data 2011 to 2024 (Schedule D 7.B.(1) private funds, Schedules A/B, 1.I websites)
- H•••• I••••• M•••••••• R•••••• · Legal Officer · since Sep 1, 2022 SEC Form ADV filing data 2011 to 2024 (Schedule D 7.B.(1) private funds, Schedules A/B, 1.I websites)
Portfolio
10 relationships, 0 platforms, 0 add-ons
Transactions
0 on record
No transaction naming this firm has been collected yet. The deal tape is read from SEC filings and cited announcements.
Placement agents, lenders, advisers and co-investors
0 relationships
No counterparty collected yet. These are counted from transactions that name both this firm and the other party, and from placement agents on this firm’s funds.
LP commitments
0 disclosed
No LP commitment collected yet. An LP edge needs a public disclosure with a quote, such as a pension plan’s report or an announcement naming the LP.
Events
4 most recent
- Jul 6, 2026News 2026-07-06 Greenfood completes divestment of Fresh Produce business Greenfood has completed the previously announced divestment of its Fresh Produce business to Dole Nordic AB.
- Dec 17, 2025News 2025-12-17 Grenfood signs agreement to sell its Fresh Produce business Greenfood has announced that it has entered into an agreement with Dole Nordic AB regarding the sale of Greenfood’s Fresh Produce business.
- Nov 24, 2025News 2025-11-24 Vimian appoints Alireza Tajbakhsh as Chief Executive Officer Alireza Tajbakhsh joined Vimian in 2021 and most recently held the role as Head of the Veterinary Services segment and interim Head of the MedTech segment in Vimian.
- Nov 17, 2022F•••••• C•••••• A••••••• A• first filed Form ADV in the extract (ERA)